title: Induction of cardiomyopathy in severe combined immunodeficiency mice by transfer of lymphocytes from patients with idiopathic dilated cardiomyopathy.
abstract: Growing evidence suggests that autoimmune mechanisms play an important role in the pathogenesis of idiopathic dilated cardiomyopathy (DCM). The aim of the study was to evaluate the effects of transfer of lymphocytes from patients with DCM into severe combined immunodeficiency (SCID) mice on the heart structure and function. Thirty CB-17 SCID (6-8 weeks old) mice were used and divided into 3 groups (n = 10). Mice were injected intraperitoneally with up to 25 x 10(6) peripheral blood lymphocytes (PBL) from either patients with DCM which contain human autoantibodies against cardiac beta1-adrenergic receptors and M2-muscarinic receptors (DCM group) or PBL from healthy controls (control-H group). Ten mice did not receive any injections and were used as baseline controls (control-N group). Echocardiography and morphological studies were performed seventy five days after the transfer. Results showed that in DCM group, left ventricle dimensions (LVD) in diastole were increased (4.2 +/- 0.1mm) as compared to both control-H group (3.8 +/- 0.1mm) and control-N group (3.6 +/- 0.1 mm) (p < 0.01). Further, there was a trend for increased LVD in systole. Fractional shortening was not different between groups. Histological evaluation revealed accumulation of human lymphocytes in the capillaries and scarce infiltration of the lymphocytes in the hearts from DCM group. Diffuse fibrosis was significant increased in DCM mice as compared to mice receiving PBL from normal subjects (2.2 +/- 0.3% vs. 0.8 +/- 0.1%, p < 0.01). In conclusion, transfer of the PBL from the patients with DCM was able to induce early stage of heart dilatation in SCID mice. These data provide for the first time the direct evidence supporting that the autoimmune mechanism is important in the pathogenesis of human DCM.
authors.affiliation: Dept of Clinical Physiology, Sahlgrenska University Hospital, Göteborg, Sweden.
authors.forename: E
authors.initials: E
authors.lastname: Omerovic
authors.forename: E
authors.initials: E
authors.lastname: Bollano
authors.forename: B
authors.initials: B
authors.lastname: Andersson
authors.forename: V
authors.initials: V
authors.lastname: Kujacic
authors.forename: W
authors.initials: W
authors.lastname: Schulze
authors.forename: A
authors.initials: A
authors.lastname: Hjalmarson
authors.forename: F
authors.initials: F
authors.lastname: Waagstein
authors.forename: M
authors.initials: M
authors.lastname: Fu
mesh_terms: D000818:Animals; D001323:Autoantibodies / Q000097:blood / Q000276:immunology; D001324:Autoantigens / Q000276:immunology; D002311:Cardiomyopathy, Dilated / Q000276:immunology* / Q000473:pathology*; D004452:Echocardiography / Q000379:methods; D006352:Heart Ventricles / Q000473:pathology*; D006801:Humans; D017710:Lymphocyte Transfusion; D008214:Lymphocytes / Q000276:immunology*; D051379:Mice; D016513:Mice, SCID; D009206:Myocardium / Q000473:pathology; D043585:Receptor, Muscarinic M2; D018342:Receptors, Adrenergic, beta-1 / Q000276:immunology; D011976:Receptors, Muscarinic / Q000276:immunology; D014183:Transplantation, Heterologous
chemical_list: D001323:Autoantibodies; D001324:Autoantigens; D043585:Receptor, Muscarinic M2; D018342:Receptors, Adrenergic, beta-1; D011976:Receptors, Muscarinic